
The Wheldon CAP is a combined antibiotic protocol (CAP) designed to kill Chlamydia pneumoniae (Cpn), a very infectious bacteria thought by some medical professionals to be the cause behind many autoimmune disorders, like Multiple Sclerosis (MS).
The research into Cpn being a causative agent for MS originated with Doctors Stratton and Sriram at Vanderbilt University in Tennessee. They determined that to eradicate Cpn, a combined antibiotic protocol is required. Unfortunately, the first CAPs created by Stratton and Sriram were not easily tolerated by patients. In late 2003, Dr. David Wheldon joined the fight against Cpn while researching treatments for his wife Sarah, who had secondary progressive MS. Proclaiming he was successful in stopping her progression and reversing most of her neurological issues, he presented to the world the Wheldon CAP.
The Wheldon CAP focused on the elimination of Cpn, with the strategic use of three antibiotics. The combination was purported to eliminate the risk of developing antibiotic-resistant bacteria. Unfortunately, when the Cpn die they release toxins which make patients experience flu-like symptoms called ‘die off’. Patients were advised to do the CAP continuously, until there was no more die off. And due to the bacteria’s tenacious nature, it was assumed it would take years to completely rid a patient of Cpn. The antibiotics also kill off the good bacteria in the gut (ie. Probiotics), which negatively affects the immune system.
The Wheldon CAP was never approved by the AMA for the treatment of MS or any other autoimmune disorder. People who tried the Wheldon CAP, did so on their own, at their own risk, most without a doctor’s supervision. The only help and support was found at an online support group dedicated to the Wheldon CAP.
MY EXPERIENCE
Discovering the Wheldon CAP in 2011, I reviewed the research, joined the support group, and committed to the CAP. I did the CAP for several years. Even though I never experienced anything that confirmed that Cpn is the cause behind MS, I do believe the CAP helped me manage my MS. Before I learned about the CAP, I discovered that inflammation causes MS relapses, with relapses being the worsening of current or creation of new MS symptoms. The CAP’s antibiotics protected me from infections, and since infections are inflammation triggers, the antibiotics protected me from MS relapses too.
Unfortunately, the Wheldon CAP also took its toll on me, from the cost of the antibiotics, and recommended supplements, to the debilitating die-off. The continuous antibiotics also made my Candidiasis, another inflammation trigger, much harder to manage. I took a lot of flak from my doctors when they found out I was taking continuous antibiotics. And yet, I never became patient zero for an antibiotic-resistant ‘super bug’, because of the combined antibiotics. I don’t regret doing the Wheldon CAP. I learned a lot, but I’d never advise anyone to do it now. I have found much easier ways to manage MS, by simply managing inflammation.
Being a part of the online support group meant a lot to me. At the time, it was one of the few sources of support I could count on. It was a rebel movement that spanned the globe and I’m proud to have been a part of it. I ended up leaving the group when my life became increasingly chaotic and I just couldn’t juggle it all. I regret that. With Dr. Wheldon’s passing in 2021 and the online support group no longer around, I think it’s time to put the Wheldon CAP to bed.
-Jen, aka. Power Chair Dorothy
References
Buljevac, D., Verkooyen, R. P., Jacobs, B. C., Hop, W., van der Zwaan, L. A., van Doorn, P. A., & Hintzen, R. Q. (2003). Chlamydia pneumoniae and the risk for exacerbation in multiple sclerosis patients. Annals of Neurology, 54(6), 828-31.
Grayston, J. T. (2000). Background and Current Knowledge of Chlamydia pneumoniae and Atherosclerosis. The Journal of Infectious Diseases, 181(3), S402–S410.
Munger, K. L., Peeling, R. W., Hernán, M. A., Chasan-Taber, L., Olek, M. J., Hankinson, S. E., Hunter, D., & Ascherio, A. (2003). Infection with Chlamydia pneumoniae and risk of multiple sclerosis. Epidemiology, 14(2), 141-147.
Sriram, S., Mitchell, W., & Stratton, C. W. (1998). Multiple Sclerosis Associated with Chlamydia pneumoniae Infection of the CNS. Neurology, 50(2), 571-572.
Sriram, S., Stratton, C. W., Yao, S., Tharp, A., Ding, L., Bannan, J. D., & Mitchell, W. M. (1999). Chlamydia pneumoniae infection of the central nervous system in multiple sclerosis. Annals of Neurology, 46(1), 6-14.
Sriram, S., Ljunggren-Rose, A., Yao, S. Y., & Whetsell, W. O. (2005). Detection of Chlamydial Bodies and Antigens in the Central Nervous System of Patients with Multiple Sclerosis. The Journal of Infectious Diseases, 192(7), 1219–1228.
Stratton C. W. (2016) . A Review of Multiple Sclerosis as an Infectious Syndrome. Journal of Neurology & Neurophysiology, 7.
Yamaguchi, H., Friedman, H., Yamamoto, M., Yasuda, K., & Yamamoto, Y. (2003). Chlamydia pneumoniae resists antibiotics in lymphocytes. Antimicrobial agents and chemotherapy, 47(6), 1972–1975.
Not in Kansas Anymore (www.notinksanymore.com) is a site/blog authored and managed by Jen, aka. Power Chair Dorothy (pwrchr-dorothy). This site/blog is intended to provide educational and research information, and to share the author’s journey.
The author of this site/blog is not a medical physician and this site/blog does not provide medical advice. This site/blog contains information that should not be used in place of a visit, call, consultation or the advice of your physician or other qualified healthcare provider. If you choose to apply or implement any information posted at this site/blog, you do so at your own risk.

